hydroxychloroquine
Showing 1 - 16 of 16
Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)
Not yet recruiting
- Hydroxychloroquine
- +2 more
- Hydroxychloroquine Combined With Gemcitabine
- (no location specified)
Dec 3, 2022
At Heart of Matter - Speckle Tracking Echocardiography in Lupus
Recruiting
- Systemic Lupus Erythematosus
- +7 more
-
Montreal, Quebec, CanadaMontreal General Hospital
Aug 8, 2022
Covid-19 Infection, Rheumatoid Arthritis, Psoriatic Arthritis Trial in Edmonton (Hydroxychloroquine/Chloroquine)
Active, not recruiting
- Covid-19 Infection
- +3 more
- Hydroxychloroquine/Chloroquine
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jul 19, 2022
Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic acid, Low-dose aspirin)
Recruiting
- Hydroxychloroquine
- Hydroxychloroquine
- +3 more
-
Assiut, EgyptAbdel-rahman Mahmoud Mohammed
Jul 21, 2021
Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic Acid, Low-dose aspirin)
Active, not recruiting
- Hydroxychloroquine
- Hydroxychloroquine
- +3 more
-
Assiut, EgyptAbdel-rahman Mahmoud Mohammed
Jul 21, 2021
Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)
Enrolling by invitation
- Hydroxychloroquine
- +3 more
- Hydroxychloroquine Sulfate
- Bromhexine 8 MG
-
Mexico City, Cdmx, MexicoNational Institute of Rehabilitation, Luis Guillermo Ibarra Ibar
Jun 26, 2021
COVID19, Hydroxychloroquine, Prophylaxis Trial in Meldola (Hydroxychloroquine)
Active, not recruiting
- COVID19
- +4 more
-
Meldola, FC, ItalyIrst Irccs
Feb 11, 2021
Sars-CoV2, Coronavirus Infection, Prevention & Control Trial (Hydroxychloroquine Only Product in Oral Dose Form)
Not yet recruiting
- Sars-CoV2
- +4 more
- Hydroxychloroquine Only Product in Oral Dose Form
- (no location specified)
Sep 26, 2020
COVID19, Sars-CoV2, Hydroxychloroquine Trial in Tunis (Hydroxychloroquine (HCQ), Placebo oral tablet)
Withdrawn
- COVID19
- +4 more
- Hydroxychloroquine (HCQ)
- Placebo oral tablet
-
Tunis, TunisiaEshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Aria
Aug 26, 2020
COVID-19, SARS-CoV-2, Pregnant Women Trial (hydroxychloroquine sulfate 200 MG, Placebo oral tablet)
Withdrawn
- COVID-19
- +3 more
- hydroxychloroquine sulfate 200 MG
- Placebo oral tablet
- (no location specified)
Jun 23, 2020
Ivermectin, Hydroxychloroquine, COVID19 Trial in Cox's Bazar (Ivermectin + Doxycycline, Hydroxychloroquine + Azithromycin)
Completed
- Ivermectin
- +2 more
- Ivermectin + Doxycycline
- Hydroxychloroquine + Azithromycin
-
Cox's Bazar, BangladeshChakoria Upazilla Health Complex
Jun 14, 2020
COVID-19, Favipiravir, Kaletra Trial in Tehran (Favipiravir, Hydroxychloroquine, Lopinavir / Ritonavir)
Completed
- COVID-19
- +4 more
- Favipiravir
- +2 more
-
Tehran, Iran, Islamic Republic ofMohammad Sadegh Bagheri Baghdasht
Jun 12, 2020
Myocardial Infarction, Acute Coronary Syndrome, Inflammation Trial in Finland (Hydroxychloroquine, Placebo)
Completed
- Myocardial Infarction
- +5 more
- Hydroxychloroquine
- Placebo
-
Helsinki, Finland
- +5 more
Jun 6, 2020
Prophylaxis, COVID-19, Health Care Worker Trial in New York (Hydroxychloroquine Pre-Exposure Prophylaxis, Placebo oral tablet)
Unknown status
- Prophylaxis
- +3 more
- Hydroxychloroquine Pre-Exposure Prophylaxis
- Placebo oral tablet
-
New York, New YorkThe New York Center for Travel and Tropical Medicine
Apr 20, 2020
IgA Patients, Hydroxychloroquine Trial in BeiJing (Hydroxychloroquine Sulfate, Placebo)
Completed
- IgA Patients
- Hydroxychloroquine
- Hydroxychloroquine Sulfate
- Placebo
-
BeiJing, Beijing, ChinaPeking University First Hospital
Feb 2, 2018